
Sigma Genetics
Sigma Genetics is a YC Winter 2017 (W17) company. Based in Seattle, WA, USA. Team of 2.
About Sigma Genetics
Summary
Sigma Genetics develops a magnetic-field-based intracellular delivery platform that transports DNA, RNA, and other charged molecules into cells. The technology replaces conventional electroporation, eliminating electrical arcing, enabling scalable workflows, and supporting non-invasive in vivo delivery. Target applications span cell therapy, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.
From the Y Combinator listing
Sigma Genetics is a biotechnology company that is building…
Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.
Facts
- Healthcare / Healthcare -> Therapeutics
- Seattle, WA, USA
- 2
- Active
- Early
Founders (3)
- Chris Pihl
- Matthew Scholz
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works